| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |